Navigation Links
AAAS Symposium: Emerging threats to tropical, temperate and ocean ecosystems
Date:2/14/2009

Three outspoken conservation scientists will present the AAAS Symposium, "Emerging Threats and Research Challenges for Global Ecosystems" on Friday, Feb. 13 at 10:30.

William Laurance, senior staff scientist at the Smithsonian Tropical Research Institute, and symposium moderator, recently co-organized a major event, "Debating the Tropical Extinction Crisis" at the National Museum of Natural History in Washington, which was featured in the New York Times, Science and The Economist. Laurance's research focuses on assessing the impacts of intensive land-use, such as habitat fragmentation, logging and wildfires on tropical ecosystems. He is broadly interested in climate change, global warming and other global change processes. A prolific author of both scientific and popular articles, Laurance is a major advocate for tropical forest conservation.

On Jan. 30, Laurance, with Thomas Lovejoy, research associate at STRI and Biodiversity Chair at the H. John Heinz III Center for Science, Economics and the Environment, received the prestigious 2008 BBVA Foundation Frontiers of Knowledge Award in Ecology and Conservation Biology, including a cash prize of 400,000 euros, largely for their contribution to the understanding of forest fragmentation, which they have effectively communicated to policy makers, resulting in significant conservation advances.

Jeremy Jackson, emeritus staff scientist at the Smithsonian Tropical Research Institute and professor of oceanography at Scripps Institution of Oceanography, has worked closely with the media to create public awareness of the effects of historical overfishing on the world's oceans and the importance of marine reserves. Jackson won the 2006 BBVA prize for Ecology and Conservation Biology.

Bruce Stein, formerly vice president and chief scientist at Natureserve, and now with the National Wildlife Federation, will use long-term research and practical conservation experience in North America to synthesize c
'/>"/>

Contact: Beth King
kingb@si.edu
202-503-6010
Smithsonian Tropical Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Emerging (disease) markets
2. Emerging field of neuroecology is showcased in December issue of the Biological Bulletin
3. The emerging story of plant roots
4. The emerging scientific discipline of aeroecology
5. Grant supports emerging field of massive data analysis and visual analytics
6. INCF organizes the first congress dedicated to the emerging field of neuroinformatics
7. World leaders in infectious diseases convene to discuss emerging global viruses
8. NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area
9. UD research study to shed light on emerging seaborne pathogen
10. ASM biodefense and emerging diseases research meeting
11. Forest Service launches Web-based forest threats viewing tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... aimed at improving the food intake, health and quality ... is among three projects at the University of Waterloo ... Canadian Institutes of Health Research (CIHR). , Professor ... at Waterloo, and a Schlegel research chair in nutrition ... investigate why many Canadians living in long-term care homes ...
(Date:8/21/2014)... Wednesday, Oct. 18-22, 2014 , WHERE: , ... San Diego, CA 92101 , WHAT: , ... of the latest research in human genetics. Examples ... high-scoring abstracts on rare genetic variants in health ... treatment for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2
... (UW) have reported for the first time that mammals can ... retinas. Located in the back of the eye, the retina,s ... to the brain. The findings on retina self-repair in ... of the Proceedings of the National Academy of Sciences ...
... Institute of Technology has invited a longtime University of ... and presenting seminars on its campus. Fazle Hussain, ... Engineering, was the sole recipient of the Gordon and ... for Caltech,s division of engineering and applied sciences. The ...
... University have answered a fundamental question of how important ... function, a finding that could provide a new target ... diseases. In a study published this month in ... show for the first time that the specific movements ...
Cached Biology News:Mammals can be stimulated to regrow damaged inner retina nerve cells 2Mammals can be stimulated to regrow damaged inner retina nerve cells 3Celebrated UH researcher invited to Caltech as distinguished scholar 2Scientists present 'moving' theory behind bacterial decision-making 2
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pursuit ... selling optimization technology and services for Life Sciences ... “Grading Pharma’s Use of New Commercial Sales Models” ... & Analytics. , The article examines some innovative ... that are being tested in the pharmaceutical market. ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... full service biopharmaceutical contract development and manufacturing organization ... by Progenics Pharmaceuticals, Inc., an oncology company focused ... and treating cancer, to manufacture the anti-prostate specific ... PSMA ADC product candidate. Under the agreement ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, ... Signaling molecules, became available for purchase in Australia and New ... that RENU 28 works is, if you think about the ... rate of cellular renewal within your body. If you think ... rate of cellular renewal. What RENU 28 does is it ...
(Date:8/20/2014)... An analysis of patented university inventions licensed to ... path to commercialization. To open these roadblocks, the ... results during the discovery stage could lead to ... are frequently derived from discoveries made in university ... well known during clinical trials, which have a ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3RENU 28 Skin Care Now Available in Australia and New Zealand 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... DRRX ) announced today that a New ... submitted to the U.S. Food,and Drug Administration (FDA). ... formulation of oxycodone intended to treat moderate to ... designed to resist,common methods of prescription drug misuse ...
... to advance Merrimack,s robust pipeline of biologics ... targeting autoimmune disease and cancer, CAMBRIDGE, Mass., ... the discovery and development of,novel treatments for autoimmune disease and ... Series F private equity financing., Existing and new investors ...
... Bioheart, Inc.,(Nasdaq: BHRT ) today announced that ... common stock to the Nasdaq Capital Market. The Company,s,common ... to The,Nasdaq Capital Market at the opening of business ... a tier of the Nasdaq Stock Market for,companies with ...
Cached Biology Technology:New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5Merrimack Pharmaceuticals Raises $60 Million in Private Financing 2Bioheart, Inc. to Transfer to Nasdaq Capital Market 2
Human Cystatin F MAb (Clone 292103)...
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
Biology Products: